当前位置:首页 - 行情中心 - 特宝生物(688278) - 财务分析 - 现金流量表

特宝生物

(688278)

  

流通市值:182.75亿  总市值:182.75亿
流通股本:4.08亿   总股本:4.08亿

现金流量表

报告期2026-09-302026-06-302026-03-312025-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金2,913,116,761.562,038,763,210.52983,596,732.233,370,745,401.21
  收到的税费返还72,318.052.31-1,053,779.86
  收到其他与经营活动有关的现金59,753,110.2424,949,063.3616,455,316.2939,063,145.28
  经营活动现金流入小计2,972,942,189.852,063,712,276.191,000,052,048.523,410,862,326.35
  购买商品、接受劳务支付的现金260,352,856.18191,127,429.4362,984,102.21273,886,111.15
  支付给职工以及为职工支付的现金972,824,689.18677,814,455.76381,606,611.49947,436,617.8
  支付的各项税费436,275,105.8307,016,783.21153,223,681.09263,713,378.45
  支付其他与经营活动有关的现金993,818,508.75551,209,745.45267,855,445.971,196,450,350.09
  经营活动现金流出小计2,663,271,159.911,727,168,413.85865,669,840.762,681,486,457.49
  经营活动产生的现金流量净额309,671,029.94336,543,862.34134,382,207.76729,375,868.86
二、投资活动产生的现金流量:
  收回投资收到的现金952,208,399.07861,805,068.56601,931,826.711,559,427,565.98
  处置固定资产、无形资产和其他长期资产收回的现金净额1,994,382.981,986,382.98760745,790.53
  收到的其他与投资活动有关的现金--9,215,949.87-
  投资活动现金流入小计954,202,782.05863,791,451.54611,148,536.581,560,173,356.51
  购建固定资产、无形资产和其他长期资产支付的现金219,932,225.04144,870,260.5974,873,480.2256,143,258.1
  投资支付的现金1,954,381,189.95477,000,000267,000,0001,745,966,623.84
  取得子公司及其他营业单位支付的现金---58,394,721.08
  投资活动现金流出小计2,174,313,414.99621,870,260.59341,873,480.22,060,504,603.02
  投资活动产生的现金流量净额-1,220,110,632.94241,921,190.95269,275,056.38-500,331,246.51
三、筹资活动产生的现金流量:
  吸收投资收到的现金---54,439,826.4
  取得借款收到的现金2,174,246,545.4621,400,00041,500,000140,670,352.2
  筹资活动现金流入小计2,174,246,545.4621,400,00041,500,000195,110,178.6
  偿还债务支付的现金28,635,813.4823,592,924.2427,616,299.4-
  分配股利、利润或偿付利息支付的现金255,430,523.85252,663,218.42613,691.66252,874,306.73
  支付其他与筹资活动有关的现金617,677,936.18608,501,313.673,417,140.179,393,732.25
  筹资活动现金流出小计901,744,273.51884,757,456.3331,647,131.23262,268,038.98
  筹资活动产生的现金流量净额1,272,502,271.89-263,357,456.339,852,868.77-67,157,860.38
四、汇率变动对现金及现金等价物的影响-479,225.24-795,030.06-24,947.16-549,425.9
五、现金及现金等价物净增加额361,583,443.65314,312,566.9413,485,185.75161,337,336.07
  加:期初现金及现金等价物余额522,853,034.5522,853,034.5522,853,034.5361,515,698.43
  期末现金及现金等价物余额884,436,478.15837,165,601.4936,338,220.25522,853,034.5
补充资料:
  净利润-476,526,946.01-1,031,236,252.58
  固定资产和投资性房地产折旧-44,667,448.91-67,097,292.45
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-44,667,448.91-67,097,292.45
  无形资产摊销-30,423,325.28-49,189,014.34
  长期待摊费用摊销-10,097,227.84-21,405,483.71
  处置固定资产、无形资产和其他长期资产的损失--1,660,577.95-718,026.13
  固定资产报废损失-430,660.28-269,228.25
  公允价值变动损失--509,982.19--3,448,015.83
  财务费用-2,480,833.42-1,971,417.52
  投资损失--2,298,419.1--6,599,263.41
  递延所得税--17,419,341.49--21,659,765.43
  其中:递延所得税资产减少--17,442,547.87--28,422,780.7
    递延所得税负债增加-23,206.38-6,763,015.27
  存货的减少--30,672,889.51--164,064,868.87
  经营性应收项目的减少--142,450,609.91--405,579,582.89
  经营性应付项目的增加--70,808,765.65-88,480,145.44
  其他-30,290,022.01-61,855,511.2
  现金的期末余额-837,165,601.4-522,853,034.5
  减:现金的期初余额-522,853,034.5-361,515,698.43
  现金及现金等价物的净增加额-314,312,566.9-161,337,336.07
公告日期2026-10-232026-08-192026-04-292026-03-27
审计意见(境内)标准无保留意见
TOP↑